Co-Authors
This is a "connection" page, showing publications co-authored by David Nemazee and Ronald McLawhon.
Connection Strength
0.118
-
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses. J Appl Lab Med. 2021 09 01; 6(5):1109-1122.
Score: 0.060
-
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2. Clin Chem. 2021 01 30; 67(2):404-414.
Score: 0.058